Washington Trust’s Cerence CRNC Stock Holding History

Washington Trust’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-37	Closed	-$1K	–	969
2022 Q3	$1K	Hold	37	–	–	﹤0.01%	848
2022 Q2	$1K	Buy	+37	New	+$1.11K	﹤0.01%	851
2020 Q2	–	Sell	-11	Closed	–	–	898
2020 Q1	$0	Buy	+11	New	+$231	﹤0.01%	952

Other funds holding CRNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Washington Trust's CRNC Position: Q4 2022 in Review

Washington Trust sold out of Cerence (CRNC) in Q4 2022, closing a stake of 37 shares — an estimated $1K sold.

Washington Trust first reported a position in CRNC in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 223 funds tracked by Wall St. Rank hold CRNC as of Q4 2022.

Washington Trust reported no remaining Cerence position as of Q4 2022 after selling out during the quarter.
Washington Trust sold 37 Cerence shares in Q4 2022, an estimated $1K.
Washington Trust first reported a position in Cerence in Q1 2020 and held it in 3 quarters.
Washington Trust's Cerence position peaked at $1K in Q3 2022.
223 funds tracked by Wall St. Rank held Cerence as of Q4 2022.

Based on Washington Trust's 13F filing for Q4 2022, filed 8 Feb 2023.